Latest Share Chat

DDDD.L Share News (DDDD)

DDDD.L Information

There is currently no data for DDDD

4D Pharma Gets Approval To Restart Thetanix Phase I Clinical Study

Fri, 10th Jun 2016 07:30

LONDON (Alliance News) - 4D Pharma PLC said Friday the UK Medicines & Healthcare Products Regulatory Agency has granted approval for 4D's phase I clinical study of Thetanix in pediatric Crohn's disease to be restarted.

The trial had been delayed as a precaution due to concerns about quality that had come to light at one of 4D's supply partners during the manufacture of an additional batch of Thetanix.

4D Pharma said that its own investigation into the matter had been completed.

Shares in 4D Pharma were up 2.6% at 880.00 pence Friday morning.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

More News

8 Apr 2016 08:25

4D Pharma Buys Assets From Partner In Deal Worth Up To EUR6 Million (ALLISS)

31 Mar 2016 08:47

4d Pharma Annual Loss Widens On Higher Research Spending

26 Feb 2016 15:49

Good news, and some not-so-good news from 4D pharma

(ShareCast News) - 4D pharma brought some good news and some bad news to the market on Friday, over its trials of irritable bowel syndrome (IBS) treatment Blautix, and it paediatric Crohn's disease treatment Thetanix. The AIM-traded pharmaceutical company, with a focus on the development of live bio

26 Feb 2016 09:16

4D Pharma Quality Concerns Delay Thetanix Dosing, Recruits For Blautic

10 Feb 2016 15:12

4D Pharma expands research with Tuscana acquisition

(ShareCast News) - 4D Pharma expanded its research capabilities on Wednesday, acquiring university-based startup Tuscana Health Limited. The AIM traded pharmaceutical company, focused on the development of live biotherapeutics, said Tuscana - based at University College Cork - was founded to investi

10 Feb 2016 08:57

4D Pharma Acquires University Start-Up Company Tucana Health (ALLISS)

19 Jan 2016 07:51

4d Pharma Gets Good Early Results From Blautix Trials

8 Dec 2015 07:46

4d Pharma Raises GBP30.0 Million For Business Development (ALLISS)

26 Nov 2015 10:10

4D Pharma Finds Live Biotherapeutic For Breast, Lung Cancer Treatment

11 Nov 2015 11:15

4D Pharma Gets Approval For Phase 1 Study Of Crohn's Disease Drug

29 Sep 2015 12:08

4D Pharma Progresses Pipeline As It Swings To Loss In First Half

21 Aug 2015 06:49

4D Pharma Commences Dosing In Irritable Bowel Syndrome Clinical Trial

11 Aug 2015 14:15

FTSE 250 movers: Miners drag index down, Synthomer spikes higher

(ShareCast News) - The FTSE 250 index was by late on Tuesday afternoon giving up some of the gains made late the day before, as commodities-focused stocks were hit by China's devaluation and corporate news received mixed reviews. By 1540 BST the index was down 0.47% at 17,677.29 points, with Vedanta

7 Aug 2015 06:31

4D Pharma Agrees EUR4.8 Million Collaboration With APC Microbiome

16 Jun 2015 08:33

4D Pharma posts "exciting" development results from MicroRx

Pharmaceutical company 4D Pharma said it had made significant progress in its research efforts using its proprietary platform MicroRx. The Manchester-based outfit was able to identify candidates for the treatment of severe asthma, allergic asthma and rheumatoid arthritis. The group also identified

Latest Share Chat

DDDD.L Share News (DDDD)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

4D Pharma Gets Approval To Restart Thetanix Phase I Clinical Study

Login to your account

Quickpicks are a member only feature

Login to your account